Eye90 microspheres® for treating unresectable liver cancer

from ResearchPod · host ResearchPod

Current imaging options to assess the responses of liver cancer patients to treatment suffer from blurry resolution, making it hard to develop radiotherapy plans. Eye90 Microspheres, developed by ABK Biomedical, enables superior CT-based dosimetry , allowing for more more accurate dose estimates for treatment planning. This work was awarded the Best Paper of the Year in the journal EJNMMI, and is being further assess in the Route90 Study.Read the original research: https://doi.org/10.1186/s40658-022-00447-1

Episode metadata supplied by the publisher feed · Published Nov 15, 2023

Embed this episode

Attribution link and audio player

Ready to play

Eye90 microspheres® for treating unresectable liver cancer

0:00 11:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ResearchPod?

This episode is 11 minutes long.

When was this ResearchPod episode published?

This episode was published on November 15, 2023.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this ResearchPod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!